Follow
Ahmed Besheer, PhD
Ahmed Besheer, PhD
DSM Nutritional Products
Verified email at dsm.com
Title
Cited by
Cited by
Year
Hydrophobically modified hydroxyethyl starch: synthesis, characterization, and aqueous self-assembly into nano-sized polymeric micelles and vesicles
A Besheer, G Hause, J Kressler, K Mäder
Biomacromolecules 8 (2), 359-367, 2007
1782007
Characterization of PLGA nanospheres stabilized with amphiphilic polymers: hydrophobically modified hydroxyethyl starch vs pluronics
A Besheer, J Vogel, D Glanz, J Kressler, T Groth, K Mäder
Molecular pharmaceutics 6 (2), 407-415, 2009
1102009
Controlled shielding and deshielding of gene delivery polyplexes using hydroxyethyl starch (HES) and alpha-amylase
M Noga, D Edinger, W Rödl, E Wagner, G Winter, A Besheer
Journal of controlled release 159 (1), 92-103, 2012
932012
Protein HESylation for half-life extension: synthesis, characterization and pharmacokinetics of HESylated anakinra
R Liebner, R Mathaes, M Meyer, T Hey, G Winter, A Besheer
European Journal of Pharmaceutics and Biopharmaceutics 87 (2), 378-385, 2014
902014
Influence of particle geometry and PEGylation on phagocytosis of particulate carriers
R Mathaes, G Winter, A Besheer, J Engert
International Journal of Pharmaceutics 465 (1-2), 159-164, 2014
872014
The effect of molar mass and degree of hydroxyethylation on the controlled shielding and deshielding of hydroxyethyl starch-coated polyplexes
M Noga, D Edinger, R Kläger, SV Wegner, JP Spatz, E Wagner, G Winter, ...
Biomaterials 34 (10), 2530-2538, 2013
822013
Comparative Investigations on In Vitro Serum Stability of Polymeric Micelle Formulations
T Miller, R Rachel, A Besheer, S Uezguen, M Weigandt, A Goepferich
Pharmaceutical research 29, 448-459, 2012
792012
Enzymatically catalyzed HES conjugation using microbial transglutaminase: Proof of feasibility
A Besheer, TC Hertel, J Kressler, K Mäder, M Pietzsch
Journal of pharmaceutical sciences 98 (11), 4420-4428, 2009
762009
Non-spherical micro-and nanoparticles: fabrication, characterization and drug delivery applications
R Mathaes, G Winter, A Besheer, J Engert
Expert opinion on drug delivery 12 (3), 481-492, 2015
742015
Loading and mobility of spin-labeled insulin in physiologically responsive complexation hydrogels intended for oral administration
A Besheer, KM Wood, NA Peppas, K Mäder
Journal of Controlled Release 111 (1-2), 73-80, 2006
682006
Physico-chemical characterization of polysaccharide-coated nanoparticles
C Lemarchand, R Gref, S Lesieur, H Hommel, B Vacher, A Besheer, ...
Journal of controlled Release 108 (1), 97-111, 2005
682005
The role of polysorbate 80 and HPβCD at the air-water interface of IgG solutions
T Serno, E Härtl, A Besheer, R Miller, G Winter
Pharmaceutical research 30, 117-130, 2013
502013
Application of different analytical methods for the characterization of non-spherical micro-and nanoparticles
R Mathaes, G Winter, J Engert, A Besheer
International journal of pharmaceutics 453 (2), 620-629, 2013
482013
Calculation of injection forces for highly concentrated protein solutions
I Fischer, A Schmidt, A Bryant, A Besheer
International journal of pharmaceutics 493 (1-2), 70-74, 2015
312015
Head to head comparison of the formulation and stability of concentrated solutions of HESylated versus PEGylated anakinra
R Liebner, M Meyer, T Hey, G Winter, A Besheer
Journal of Pharmaceutical Sciences 104 (2), 515-526, 2015
312015
Tracking the urinary excretion of high molar mass poly (vinyl alcohol)
A Besheer, K Mäder, S Kaiser, J Kressler, C Weis, EK Odermatt
Journal of Biomedical Materials Research Part B: Applied Biomaterials: An …, 2007
302007
Influence of particle size, an elongated particle geometry, and adjuvants on dendritic cell activation
R Mathaes, G Winter, TJ Siahaan, A Besheer, J Engert
European Journal of Pharmaceutics and Biopharmaceutics 94, 542-549, 2015
292015
Evaluation of different quality-relevant aspects of closed system transfer devices (CSTDs)
A Besheer, HC Mahler, A Matter-Schwald, SM Barrenechea, M Vogt, ...
Pharmaceutical Research 37, 1-12, 2020
262020
Influence of hydroxypropyl‐beta‐cyclodextrin on the stability of dilute and highly concentrated immunoglobulin G formulations
E Härtl, G Winter, A Besheer
Journal of Pharmaceutical Sciences 102 (11), 4121-4131, 2013
262013
Weak antibody–cyclodextrin interactions determined by quartz crystal microbalance and dynamic/static light scattering
E Härtl, N Dixit, A Besheer, D Kalonia, G Winter
European Journal of Pharmaceutics and Biopharmaceutics 85 (3), 781-789, 2013
262013
The system can't perform the operation now. Try again later.
Articles 1–20